Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is one of the best cheap biotech stocks to buy now. Aurinia Pharmaceuticals Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 11,329,500 | $180,705,525 | 8.93% | |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,387,194 | $54,025,744 | +1% | 0.03% |
| 3. | Renaissance Technologies Jim Simons | 1,590,135 | $25,362,653 | +10% | 0.04% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,574,957 | $25,120,564 | +7% | 0.02% |
| 5. | D E Shaw D. E. Shaw | 1,532,273 | $24,439,755 | +69% | 0.01% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.22 | 184,208 | $2,619,437.76 | 12,229,500 | 2026-03-03 | Filing | |
| $14.21 | 115,792 | $1,645,404.32 | 12,045,292 | 2026-03-02 | Filing | |
| $14.33 | 83,561 | $1,197,429.13 | 11,929,500 | 2026-03-02 | Filing | |
| $14.38 | 1,600 | $23,008.00 | 11,845,939 | 2026-02-27 | Filing | |
| $14.12 | 214,839 | $3,033,526.68 | 11,844,339 | 2026-02-27 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.50 | 20,000 | $210,000.00 | 133,484 | 2025-08-01 | Filing | |
| $8.23 | 8,305 | $68,350.15 | 153,484 | 2025-03-07 | Filing | |
| $7.92 | 164,947 | $1,306,380.24 | 1,788,945 | 2025-03-04 | Filing | |
| $8.00 | 195,593 | $1,564,744.00 | 1,953,892 | 2025-03-03 | Filing | |
| $8.00 | 12,239 | $97,912.00 | 161,789 | 2025-03-03 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,928,129 | $126,453,658 | 0% | |
| 2. | 3,969,834 | $63,318,852 | 3.23% | |
| 3. | 2,501,992 | $39,906,772 | 0% | |
| 4. | 2,216,915 | $35,359,797 | 0% | |
| 5. | 1,962,742 | $31,305,735 | 0.04% |